Autoradiographic distribution of 5‐HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species

The main aim of this investigation was to delineate the distribution of the 5‐HT7 receptor in human brain. Autoradiographic studies in guinea‐pig and rat brain were also carried out in order to revisit and compare the anatomical distribution of 5‐HT7 receptors in different mammalian species. Binding studies were performed in rat frontal cortex membranes using 10 nM [3H]mesulergine in the presence of raclopride (10 μM) and DOI (0.8 μM). Under these conditions, a binding site with pharmacological characteristics consistent with those of the 5‐HT7 receptors was identified (rank order of binding affinity values: 5‐CT>5‐HT>5‐MeOT>mesulergine ∼methiothepin>8‐OH‐DPAT=spiperone ∼(+)‐butaclamol≫imipramine ∼(±)‐pindolol≫ondansetron ∼clonidine ∼prazosin). The autoradiographic studies revealed that the anatomical distribution of 5‐HT7 receptors throughout the human brain was heterogenous. High densities were found over the caudate and putamen nuclei, the pyramidal layer of the CA2 field of the hippocampus, the centromedial thalamic nucleus, and the dorsal raphe nucleus. The inner layer of the frontal cortex, the dentate gyrus of the hippocampus, the subthalamic nucleus and superior colliculus, among others, presented intermediate concentrations of 5‐HT7 receptors. A similar brain anatomical distribution of 5‐HT7 receptors was observed in all three mammalian species studied. By using [3H]mesulergine, we have mapped for the first time the anatomical distribution of 5‐HT7 receptors in the human brain, overcoming the limitations previously found in radiometric studies with other radioligands, and also revisiting the distribution in guinea‐pig and rat brain.

[1]  C. Davies,et al.  5-HT7 receptors modulate synchronized network activity in rat hippocampus , 2002, Neuropharmacology.

[2]  R. Pearson,et al.  The Human Nervous System. Basic Elements of Structure and Function , 1967, The Yale Journal of Biology and Medicine.

[3]  Terrence P. Kenakin,et al.  A Pharmacologic Analysis of Drug-Receptor Interaction , 1987 .

[4]  J. Hagan,et al.  [3H]‐SB‐269970 – A selective antagonist radioligand for 5‐HT7 receptors , 2000 .

[5]  J. Plassat,et al.  Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. , 1993, Molecular pharmacology.

[6]  L. Swanson The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .

[7]  R. Andrade,et al.  A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. II. Involvement of the hyperpolarization-activated current I(h). , 2001, The Journal of pharmacology and experimental therapeutics.

[8]  A. Sleight,et al.  Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  J. Hagan,et al.  Characterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonist , 2000, British journal of pharmacology.

[10]  D. Sibley,et al.  Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. , 1994, The Journal of pharmacology and experimental therapeutics.

[11]  P. Vincent,et al.  Serotonin suppresses the slow afterhyperpolarization in rat intralaminar and midline thalamic neurones by activating 5‐HT7 receptors , 2002, The Journal of physiology.

[12]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[13]  I. Coupar,et al.  Characterisation of a 5-HT(7) binding site in mouse ileum. , 2000, European journal of pharmacology.

[14]  T. Branchek,et al.  A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5‐ht7 receptor in rat brain , 1996, British journal of pharmacology.

[15]  A. Tsou,et al.  Cloning and Expression of a 5‐Hydroxytryptamine7 Receptor Positively Coupled to Adenylyl Cyclase , 1994, Journal of neurochemistry.

[16]  R. Cone,et al.  Cloning and expression of a 5HT7 receptor from Xenopus laevis. , 1995, Receptors & channels.

[17]  H. Baumgarten,et al.  Serotoninergic Neurons and 5-HT Receptors in the CNS , 2000, Handbook of Experimental Pharmacology.

[18]  W. Burkard,et al.  Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system. , 1999, Journal of receptor and signal transduction research.

[19]  T. Kenakin The classification of drugs and drug receptors in isolated tissues. , 1984, Pharmacological reviews.

[20]  M. Wood,et al.  Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT(7) receptor. , 2000, European journal of pharmacology.

[21]  J. Palacios,et al.  5-HT receptors in mammalian brain: receptor autoradiography andin situ hybridization studies of new ligands and newly identified receptors , 1996, The Histochemical Journal.

[22]  Guang-di Yu,et al.  The inhibitory effect of serotonin on the spontaneous discharge of suprachiasmatic neurons in hypothalamic slice is mediated by 5-HT7 receptor , 2001, Brain Research Bulletin.

[23]  R. Eglen,et al.  Characterization and distribution of putative 5‐ht7 receptors in guinea‐pig brain , 1995, British journal of pharmacology.

[24]  J. Palacios,et al.  Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. , 1984, European journal of pharmacology.

[25]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[26]  A. Eison,et al.  Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus , 1999, Neuropsychopharmacology.

[27]  D. McCormick,et al.  Neurotransmitter actions in the thalamus and cerebral cortex. , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[28]  I. Coupar,et al.  [3H]‐Mesulergine labels 5‐HT7 sites in rat brain and guinea‐pig ileum but not rat jejunum , 1999, British journal of pharmacology.

[29]  A. Closse [3H]Mesulergine, a selective ligand for serotonin-2 receptors. , 1983, Life sciences.

[30]  D. Sibley,et al.  Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. , 1993, The Journal of biological chemistry.

[31]  S. Ying,et al.  5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons , 1997, Brain Research.

[32]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[33]  J. Sutcliffe,et al.  No hypothermic response to serotonin in 5-HT7 receptor knockout mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[35]  T. Branchek,et al.  Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. , 1993, The Journal of biological chemistry.

[36]  R. Kohen,et al.  Four 5‐Hydroxytryptamine7 (5‐HT7) Receptor Isoforms in Human and Rat Produced by Alternative Splicing: Species Differences Due to Altered Intron‐Exon Organization , 1997, Journal of Neurochemistry.

[37]  G. Martin,et al.  The 5-HT7 receptor: orphan found. , 1997, Trends in pharmacological sciences.

[38]  C. Langmead,et al.  The effect of SB‐269970, a 5‐HT7 receptor antagonist, on 5‐HT release from serotonergic terminals and cell bodies , 2001, British journal of pharmacology.

[39]  M. Erlander,et al.  A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms , 1993, Neuron.

[40]  H. Saito,et al.  Inhibition by 5‐HT7 receptor stimulation of GABAA receptor‐activated current in cultured rat suprachiasmatic neurones. , 1994, The Journal of physiology.

[41]  C. Waeber,et al.  Autoradiographic visualisation of [3H]5-carboxamidotryptamine binding sites in the guinea pig and rat brain. , 1995, European journal of pharmacology.

[42]  J. Hagan,et al.  SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats , 2003, British journal of pharmacology.

[43]  R. Andrade,et al.  A 5-HT7 Receptor-Mediated Depolarization in the Anterodorsal Thalamus. II. Involvement of the Hyperpolarization-Activated Current Ih , 2001 .

[44]  S. Beck,et al.  5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. , 2000, The Journal of pharmacology and experimental therapeutics.

[45]  J. Hankinson A stereotaxic atlas of the forebrain of the guinea pig , 1968 .

[46]  A. Sleight,et al.  Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. , 1995, Molecular pharmacology.

[47]  N. Barnes,et al.  Selective labelling of 5-HT7 receptor recognition sites in rat brain using [3H]5-carboxamidotryptamine , 1998, Neuropharmacology.

[48]  Á. Pazos,et al.  Identification and Characterization of a New Serotonergic Recognition Site with High Affinity for 5‐Carboxamidotryptamine in Mammalian Brain , 1997, Journal of neurochemistry.

[49]  J. Neumaier,et al.  Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression , 2001, Journal of Chemical Neuroanatomy.

[50]  R. Heavens,et al.  Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain. , 2001, Brain research. Molecular brain research.

[51]  J. Palacios,et al.  The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. , 1984, European journal of pharmacology.

[52]  W. Olijve,et al.  Human serotonin 5‐HT7 receptor: cloning and pharmacological characterisation of two receptor variants , 1997, FEBS letters.

[53]  D. Middlemiss,et al.  [3 H]-SB-269970 radiolabels 5-HT7 receptors in rodent, pig and primate brain tissues , 2002, Neuropharmacology.

[54]  J. Leysen,et al.  5-HT7 receptors: current knowledge and future prospects. , 2000, Trends in pharmacological sciences.

[55]  J. Terrón,et al.  Role of 5-HT1A and 5-HT7 receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation , 2001, Behavioural Brain Research.

[56]  P. Szot,et al.  Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing , 1998, Neuropharmacology.

[57]  R. Eglen,et al.  Cloning, expression and pharmacology of a truncated splice variant of the human 5‐HT7 receptor (h5‐HT7(b)) , 1997 .

[58]  A. Meneses,et al.  5-HT system and cognition , 1999, Neuroscience & Biobehavioral Reviews.

[59]  K. Krobert,et al.  The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[60]  R. Mair,et al.  Learning impairments after 6-OHDA treatment: A comparison with the effects of thiamine deficiency , 1986, Behavioural Brain Research.

[61]  J. Schwartz,et al.  Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Xavier Langlois,et al.  Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice. , 2002, The Journal of pharmacology and experimental therapeutics.